Navigation Links
Diuretics are better for treating blood pressure problems than newer medicines

According to the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) // results, most effective treatment of high blood pressure seems to be diuretics of the thiazide variety that are also sometimes known as the water pills.

In the results of the study was published in this week’s The Journal of American Medical association. ALLHAT is considered one of the most important sets of trials conducted for hypertension by researchers of Case Western Reserve University, Cleveland Us and a few more centers. The trials were conducted in a cross-cultural milieu involving afro-Americans and other people.

The study was done to test the effect of various classes of anti-hypertensive drugs and adverse effects like stroke, heart failure, cardiovascular disease etc.

The results of the study said that diuretics based treatment resulted in the lowest rate of heart failure due to hyper tension in both the groups of African-Americans and Americans.

Drug chlorthalidone had more pronounced effect on some conditions of the African-Americans. However for the initial treatment of hypertension and high blood pressure, diuretics still remain the choice of the medical practitioners.


'"/>




Page: 1

Related medicine news :

1. Diuretics may decrease electrolytes level
2. Diuretics More Effective In Controlling High Blood Pressure
3. Homeopathic preparation better than placebo in perennial allergic
4. Patient’s perception of health status helps in better recover
5. For better mood and energy!! Work-up in short span
6. Antifever drug betters stroke outcome
7. Prevention is better than cure
8. A better way to measure cholesterol
9. Sponging Cattle betters spraying in eradicating Malaria
10. New therapy better at increasing bone density
11. Left handed have better episodic memory
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... 05, 2016 , ... At its annual meeting held last week, the American ... National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We ... Chambers , APDA President and CEO. “Pat has tirelessly served APDA since 2001 when ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is thrilled ... provide the most effective tattoo removal today, Dr. Bentkover is the only doctor in ... Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) as ...
(Date:2/5/2016)... ... February 05, 2016 , ... Colorize is ... one drop zone to the next using Colorize's dynamic moving camera. Colorize is perfect ... package includes a 3D slideshow environment with 1 to 5 focus points per scene, ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... Ramsey, NJ (PRWEB) , ... February 05, 2016 ... ... Optimizing Primary Care for Patients with Rare Diseases, a continuing medical education (CME) ... conference is the first of its kind—and a first for ACCORD, whose mission ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  As people age, it ... multitude of recommended screenings and tests that are linked ... priority. However, for the majority of aging individuals, hearing ... planning. For the 37.5 million American adults who report ... present to make hearing health a 2016 healthy aging ...
(Date:2/5/2016)... Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... and CEO, will be presenting at Source Capital Group,s 2016 ... NY at 2:15 p.m. ET on Wednesday, February ... Panel discussion taking place at 3:15 p.m. ET. ... one hour after the conclusion of the live event. The ...
(Date:2/5/2016)... Ind. , Feb. 5, 2016  Zimmer Biomet ... pricing of the previously announced underwritten secondary offering of ... its stockholders, consisting of affiliates of Blackstone and Goldman ... at an initial price of $96.45 per share. The ... the offering.  Neither Zimmer Biomet nor any of its ...
Breaking Medicine Technology: